Lv1
30 积分 2024-03-20 加入
Efficacy and safety of resmetirom for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis
6个月前
已完结
Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH)
6个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
6个月前
已完结
皖公网安备34019202002308
